Abstract
Atopic dermatitis (AD) is an allergic skin disease mediated by skin barrier dysfunction and an IL-13-driven immune response. The aryl hydrocarbon receptor (AHR) is a sensor molecule that is activated by numerus environmental ligands, some of which have shown promise in clinical trials of AD. Therefore, we hypothesized that the AHR pathway can attenuate IL-13-induced responses.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
